BioMarin Pharmaceutical Inc. (LON: 0HNC)
London
· Delayed Price · Currency is GBP · Price in USD
61.70
-0.42 (-0.68%)
Jan 23, 2025, 2:45 PM BST
BioMarin Pharmaceutical Employees
BioMarin Pharmaceutical had 3,401 employees as of December 30, 2023. The number of employees increased by 319 or 10.35% compared to the previous year.
Employees
3,401
Change (1Y)
319
Growth (1Y)
10.35%
Revenue / Employee
603.90K GBP
Profits / Employee
70.70K GBP
Market Cap
9.60B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
BioMarin Pharmaceutical News
- 9 days ago - BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court - PRNewsWire
- 17 days ago - BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA - PRNewsWire
- 2 months ago - Biomarin: Challanges Mount, But Sale Rumours Make For A Risky "Buy" Call - Seeking Alpha
- 2 months ago - BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024 - PRNewsWire
- 2 months ago - BioMarin to Participate in Three Upcoming Investor Conferences - PRNewsWire
- 3 months ago - BioMarin Pharmaceutical Inc. (BMRN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook - PRNewsWire
- 3 months ago - BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET - PRNewsWire